Stockscreener 앱 받기
1.18
4.42%
0.05
NanoViricides Inc 주식(NNVC)의 최신 뉴스
Aug Momentum: Is NanoViricides Inc forming a bullish divergenceTrade Analysis Summary & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn
NanoViricides Comments on the Need for Broad-Spectrum Antivirals in Light of the Current Influenza WaveNV-387 is Effective Against H3N2 - Lebanon Daily News
Support Test: Should I invest in NanoViricides Inc before earningsJuly 2025 PostEarnings & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
Jobs Data: How much upside does NanoViricides Inc have2025 Bull vs Bear & Long-Term Capital Growth Strategies - baoquankhu1.vn
NanoViricides Highlights Need for Broad-Spectrum Antivirals During Severe Influenza Season - citybuzz -
NanoViricides highlights need for broad-spectrum antivirals amid severe flu season - Proactive financial news
San Gabriel Valley Tribune - FinancialContent
Options Flow: Will NanoViricides Inc. stock continue dividend increases2025 Winners & Losers & Short-Term Swing Trade Alerts - Bộ Nội Vụ
Market Recap: Can NanoViricides Inc NV3P stock sustain institutional flowsInflation Watch & Stock Portfolio Risk Control - Bộ Nội Vụ
After-Hours Rally: Zentalis, LifeMD, And NanoViricides Among Top Gainers - Nasdaq
Published on: 2026-01-10 19:47:32 - ulpravda.ru
Volume Summary: Will NanoViricides Inc NV3P stock outperform small cap peersJuly 2025 Chart Watch & Reliable Breakout Forecasts - moha.gov.vn
NanoViricides Has Received Approval to Start Phase II Clinical Trial of NV-387 for the Treatment of MPox by the Regulatory Agency ACOREP of the Democratic Republic of Congo - The Patriot Ledger
Can NanoViricides Inc. stock outperform in 2025 bull marketJuly 2025 Weekly Recap & Reliable Price Action Trade Plans - Улправда
Can NanoViricides Inc. stock hit record highs againPortfolio Update Summary & Expert Curated Trade Setup Alerts - Улправда
NanoViricides Announces Closing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close - Times Record News
Geopolitics Watch: How analysts rate NanoViricides Inc. stock todayInflation Watch & Fast Moving Stock Trade Plans - Улправда
Inflation Data: How SUNE stock reacts to inflationary pressuresJuly 2025 Summary & Verified Technical Trade Signals - moha.gov.vn
Can NanoViricides Inc. stock sustain market leadershipJuly 2025 Market Mood & Weekly Consistent Profit Watchlists - Улправда
How risky is NanoViricides Inc. stock nowJuly 2025 Snapshot & Advanced Swing Trade Entry Alerts - Улправда
Market Review: Is NanoViricides Inc. stock oversold or undervaluedQuarterly Trade Report & Low Drawdown Trading Strategies - Улправда
How analysts rate NanoViricides Inc. stock todayQuarterly Profit Report & Weekly Stock Breakout Alerts - Улправда
Can NanoViricides Inc. stock weather global recessionBull Run & Daily Profit Focused Screening - ulpravda.ru
NanoViricides, Inc. Has Filed its Quarterly ReportSubsequent Raise Has Fortified Fiscal Position - Fall River Herald News
Is NanoViricides Inc stock oversold or undervaluedMarket Growth Review & Reliable Entry Point Trade Alerts - Bộ Nội Vụ
Profit Recap: How risky is NanoViricides Inc stock nowJuly 2025 PreEarnings & Consistent Profit Alerts - Bộ Nội Vụ
NanoViricides to Present at the Spartan Capital Investor Conference 2025 in New York City Today, November 3rd - thespectrum.com
NanoViricides Announces Pricing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close - The Coloradoan
NanoViricides to Present at the PODD 2025 Conference in Boston on October 27 - The Register-Guard
NanoViricides Has Signed a Master Services Agreement with OnlyOrphansCote Regarding Orphan Drug Strategy of NV-387 for Treatment of MPox, Smallpox, and Measles - Fall River Herald News
Treating Measles Infection: Nanoviricides CEO Dr Anil Diwan Interviewed by Steve Darling from Proactive - The Register-Guard
Hogs Drift in a Quiet Session - Barchart.com
Cotton Faces Pressure into the Close - Barchart.com
Wild Yangtze: Echoes of Life from the River’s Rare Species - Barchart.com
Stocks slip on Wall Street as 2025 winds down - Barchart.com
QuantumScape Gained 100% in 2025 and Is Set to Generate Revenue for the First Time in 2025. Options Data Suggests You Should Play QS Stock Like This for 2026. - Barchart.com
MongoDB, AppLovin, and SoundHound AI Stocks Trade Down, What You Need To Know - Barchart.com
Why RXO (RXO) Stock Is Down Today - Barchart.com
Alibaba Was the Market’s Favorite Chinese AI Stock in 2025: What’s BABA’s 2026 Forecast? - Barchart.com
After Long Preparation, Sun Star Roofing Begins Serving the Pittsburgh Area with a Comprehensive Exterior Vision - Barchart.com
Cotton Holding onto Slight Gains on Monday - Barchart.com
Short Sellers Are Betting Against Lumentum Stock. Will They Be Proven Right? - Barchart.com
Hogs Fall to Weakness on Friday - Barchart.com
2 S&P 500 Stocks to Target This Week and 1 We Brush Off - Barchart.com
2 Reasons to Watch PYPL and 1 to Stay Cautious - Barchart.com
New Year, Even Better Liquidity for Brokers in 2026 - Barchart.com
Netflix Is Out of Favor—and That’s Why It’s Getting Interesting - Barchart.com
A Systematic Exploration of Technological Risks: Hu Jiaqi’s Foresight and Practice - Barchart.com
Sidus Space Announces Pricing of Offering - Barchart.com
4.73%
0.92%
자본화:
|
볼륨(24시간):